Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
62.11
-0.59 (-0.94%)
Mar 31, 2025, 1:15 PM EDT - Market open
Verona Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$66.83
Upside
+7.60%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $74 → $93 | Buy | Maintains | $74 → $93 | +49.73% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $75 | Strong Buy | Maintains | $60 → $75 | +20.75% | Feb 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $44 → $72 | Strong Buy | Maintains | $44 → $72 | +15.92% | Feb 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $42 → $60 | Strong Buy | Reiterates | $42 → $60 | -3.40% | Jan 21, 2025 |
| Roth MKM | Roth MKM | Strong Buy Initiates $68 | Strong Buy | Initiates | $68 | +9.48% | Jan 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $64 → $74 | Buy | Maintains | $64 → $74 | +19.14% | Jan 8, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $44 → $57 | Strong Buy | Reiterates | $44 → $57 | -8.23% | Jan 8, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $50 → $64 | Buy | Maintains | $50 → $64 | +3.04% | Nov 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $42 | Strong Buy | Maintains | $36 → $42 | -32.38% | Nov 5, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $37 → $44 | Strong Buy | Maintains | $37 → $44 | -29.16% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $38 → $44 | Strong Buy | Maintains | $38 → $44 | -29.16% | Oct 9, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $50 | Buy | Initiates | $50 | -19.50% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -42.04% | Oct 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -42.04% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | -42.04% | Sep 11, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $35 → $37 | Strong Buy | Maintains | $35 → $37 | -40.43% | Jul 22, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.